<DOC>
	<DOCNO>NCT00437437</DOCNO>
	<brief_summary>The purpose trial determine effect food versus fast state single-dose pharmacokinetics BMS-540215 , active metabolite Brivanib alaninate</brief_summary>
	<brief_title>A Phase I Study Determine Effect Food Brivanib ( BMS-582664 )</brief_title>
	<detailed_description />
	<criteria>For additional information , please contact BMS oncology clinical trial information service 8552160126 email MyCancerStudyConnect @ emergingmed.com . Please visit www.BMSStudyConnect.com information clinical trial participation . Histologic/cytologic diagnosis advance metastatic solid tumor ECOG 02 4/6 week since prior therapy Brain metastases Second primary malignancy Thromboembolic disease require full anticoagulation within 6 month Inability swallow absorb oral therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Advanced metastatic solid tumor</keyword>
</DOC>